Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Backman, JT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wen, X; Wang, JS; Kivisto, KT; Neuvonen, PJ; Backman, JT
      In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P4502C9 (CYP2C9)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    2. Desta, Z; Kivisto, KT; Lilja, JJ; Backman, JT; Soukhova, N; Neuvonen, PJ; Flockhart, DA
      Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Wen, X; Wang, JS; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Gemfibrozil is a potent inhibitor of human cytochrome P4502C9

      DRUG METABOLISM AND DISPOSITION
    4. Villikka, K; Varis, T; Backman, JT; Neuvonen, PJ; Kivisto, KT
      Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    5. Kivisto, KT; Wang, JS; Backman, JT; Nyman, L; Taavitsainen, P; Anttila, M; Neuvonen, PJ
      Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    6. Niemi, M; Backman, JT; Neuvonen, M; Neuvonen, PJ; Kivisto, KT
      Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Kyrklund, C; Backman, JT; Kivisto, KT; Neuvonen, M; Laitila, J; Neuvonen, PJ
      Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    8. Niemi, M; Backman, JT; Neuvonen, M; Laitila, J; Neuvonen, PJ; Kivisto, KT
      Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    9. Niemi, M; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Valtonen, M; Tiula, E; Backman, JT; Neuvonen, PJ
      Elimination of meropenem during continuous veno-venous haemofiltration andhaemodiafiltration in patients with acute renal failure

      Journal of antimicrobial chemotherapy
    11. Wang, JS; Backman, JT; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans

      DRUG METABOLISM AND DISPOSITION
    12. Wang, JS; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Effects of metronidazole on midazolam metabolism in vitro and in vivo

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    13. Lilja, JJ; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Effect of grapefruit juice dose on grapefruit juice-triazolam interaction:repeated consumption prolongs triazolam half-life

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    14. Kantola, T; Backman, JT; Niemi, M; Kivisto, KT; Neuvonen, PJ
      Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    15. Kyrklund, C; Backman, JT; Kivisto, KT; Neuvonen, M; Laitila, J; Neuvonen, PJ
      Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    16. Varis, T; Kivisto, KT; Backman, JT; Neuvonen, PJ
      The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    17. Niemi, M; Backman, JT; Neuvonen, M; Neuvonen, PJ; Kivisto, KT
      Rifampin decreases the plasma concentrations and effects of repaglinide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    18. Backman, JT; Kyrklund, C; Kivisto, KT; Wang, JS; Neuvonen, PJ
      Plasma concentrations of active simvastatin acid are increased by gemfibrozil

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    19. Backman, JT; Maenpaa, J; Belle, DJ; Wrighton, SA; Kivisto, KT; Neuvonen, PJ
      Lack of correlation between in vitro and in vivo studies on the effects oftangeretin and tangerine juice on midazolam hydroxylation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    20. Varis, T; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    21. Niemi, TT; Backman, JT; Syrjala, MT; Viinikka, LU; Rosenberg, PH
      Platelet dysfunction after intravenous ketorolac or propacetamol

      ACTA ANAESTHESIOLOGICA SCANDINAVICA
    22. Wang, JS; Backman, JT; Wen, X; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro

      PHARMACOLOGY & TOXICOLOGY
    23. Wang, JS; Wen, X; Backman, JT; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Midazolam alpha-hydroxylation by human liver microsomes in vitro: Inhibition by calcium channel blockers, itraconazole and ketoconazole

      PHARMACOLOGY & TOXICOLOGY
    24. Varis, T; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers

      PHARMACOLOGY & TOXICOLOGY
    25. Backman, JT; Siegle, I; Zanger, UM; Fritz, P
      Immunohistochemical detection of microsomal epoxide hydrolase in human synovial tissue

      HISTOCHEMICAL JOURNAL
    26. Kivisto, KT; Lilja, TJ; Backman, JT; Neuvonen, PJ
      Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    27. Backman, JT; Wang, JS; Wen, X; Kivisto, KT; Neuvonen, PJ
      Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    28. BACKMAN JT; SIEGLE I; FRITZ P
      IMMUNOHISTOCHEMICAL LOCALIZATION OF METALLOTHIONEIN IN SYNOVIAL TISSUE OF PATIENTS WITH CHRONIC INFLAMMATORY AND DEGENERATIVE JOINT DISEASE

      Virchows Archiv
    29. BACKMAN JT; KIVISTO KT; OLKKOLA KT; NEUVONEN PJ
      THE AREA UNDER THE PLASMA CONCENTRATION-TIME CURVE FOR ORAL MIDAZOLAMIS 400-FOLD LARGER DURING TREATMENT WITH ITRACONAZOLE THAN WITH RIFAMPICIN

      European Journal of Clinical Pharmacology
    30. BACKMAN JT; SIEGLE I; FRITZ P
      QUANTITATIVE IMMUNOHISTOCHEMICAL ASSESSMENT OF METALLOTHIONEIN IN SYNOVIAL-MEMBRANE OF PATIENTS WITH INFLAMMATORY AND DEGENERATIVE JOINT DISEASE

      Naunyn-Schmiedeberg's archives of pharmacology
    31. MURDTER TE; SPERKER B; BACKMAN JT; FRIEDEL G; MCCLELLAN M; FRITZ P; BOSSLER K; KROEMER HK
      BETA-GLUCURONIDASE EXPRESSION, ACTIVITY, AND LOCALIZATION OF IN HUMANLUNG-CANCER - A BASE FOR DRUG TARGETING

      Naunyn-Schmiedeberg's archives of pharmacology
    32. Lilja, JJ; Kivisto, KT; Backman, JT; Lamberg, TS; Neuvonen, PJ
      Grapefruit juice substantially increases plasma concentrations of buspirone

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    33. SIEGLE I; KLEIN T; BACKMAN JT; SAAL JG; NUSING RM; FRITZ P
      EXPRESSION OF CYCLOOXYGENASE-1 AND CYCLOOXYGENASE-2 IN HUMAN SYNOVIALTISSUE - DIFFERENTIAL ELEVATION OF CYCLOOXYGENASE-2 IN INFLAMMATORY JOINT DISEASES

      Arthritis and rheumatism
    34. SPERKER B; BACKMAN JT; KROEMER HK
      THE ROLE OF BETA-GLUCURONIDASE IN DRUG DISPOSITION AND DRUG TARGETINGIN HUMANS

      Clinical pharmacokinetics
    35. VILLIKKA K; KIVISTO KT; BACKMAN JT; OLKKOLA KT; NEUVONEN PJ
      TRIAZOLAM IS INEFFECTIVE IN PATIENTS TAKING RIFAMPIN

      Clinical pharmacology and therapeutics
    36. BACKMAN JT; OLKKOLA KT; OJALA M; LAAKSOVIRTA H; NEUVONEN PJ
      CONCENTRATIONS AND EFFECTS OF ORAL MIDAZOLAM ARE GREATLY REDUCED IN PATIENTS TREATED WITH CARBAMAZEPINE OR PHENYTOIN

      Epilepsia
    37. BACKMAN JT; OLKKOLA KT; NEUVONEN PJ
      RIFAMPIN DRASTICALLY REDUCES PLASMA-CONCENTRATIONS AND EFFECTS OF ORAL MIDAZOLAM

      Clinical pharmacology and therapeutics
    38. BACKMAN JT; OLKKOLA KT; NEUVONEN PJ
      AZITHROMYCIN DOES NOT INCREASE PLASMA-CONCENTRATIONS OF ORAL MIDAZOLAM

      International journal of clinical pharmacology and therapeutics
    39. ARANKO K; LUURILA H; BACKMAN JT; NEUVONEN PJ; OLKKOLA KT
      THE EFFECT OF ERYTHROMYCIN ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOPICLONE

      British journal of clinical pharmacology
    40. BACKMAN JT; OLKKOLA KT; ARANKO K; HIMBERG JJ; NEUVONEN PJ
      DOSE OF MIDAZOLAM SHOULD BE REDUCED DURING DILTIAZEM AND VERAPAMIL TREATMENTS

      British journal of clinical pharmacology
    41. BACKMAN JT; ARANKO K; HIMBERG JJ; OLKKOLA KT
      A PHARMACOKINETIC INTERACTION BETWEEN ROXITHROMYCIN AND MIDAZOLAM

      European Journal of Clinical Pharmacology
    42. OLKKOLA KT; BACKMAN JT; NEUVONEN PJ
      MIDAZOLAM SHOULD BE AVOIDED IN PATIENTS RECEIVING THE SYSTEMIC ANTIMYCOTICS KETOCONAZOLE OR ITRACONAZOLE

      Clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 21:20:18